Welcome to the e-CCO Library!

P466: Real world effectiveness of vedolizumab over one year in inflammatory bowel disease: a meta-analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Schreiber S.1, Dignass A.*2, Peyrin-Biroulet L.3, Hather G.4, Demuth D.5, Khalid J.M.6, Loftus E.V.7

Created: Wednesday, 20 February 2019, 10:36 AM
P466: Real-world effectiveness and safety of golimumab in patients with ulcerative colitis: 52-weeks of post-marketing surveillance data in Japan
Year: 2022
Source: ECCO'22
Authors: Nakamura, S.(1);Asano, T.(2);Tanaka, Y.(3);Sugimoto, K.(4);Yoshigoe, S.(5);Suzuki, Y.(6);
Created: Friday, 11 February 2022, 3:52 PM
P466: Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumour necrosis factor alpha therapy: a prospective single-centre open-label study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. Hlavaty*, A. Krajcovicova, J. Letkovsky, I. Sturdik, T. Koller, J. Toth, M. Huorka

Created: Friday, 22 February 2019, 9:49 AM
P466: Tofacitinib for the treatment of ulcerative colitis: Up to 5.4 years of safety data from global clinical trials
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. J. Sandborn1, J. Panés*2, R. Panaccione3, G. R. D’Haens4, B. E. Sands5, C. Su6, M. Moscariello6, T. V. Jones6, R. D. Pedersen6, G. S. Friedman6, N. Lawendy6, G. Chan6

Created: Friday, 22 February 2019, 9:41 AM
P467 Can induction and maintenance serum vedolizumab levels predict long-term clinical outcome in inflammatory bowel disease (IBD)?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Miller1, H. Morgan2, A. Steel3, M. Wahed4

Created: Thursday, 30 January 2020, 10:12 AM
P467: 5-ASA is not superior to no-maintenance in patients with newly diagnosed Crohn's disease - a nationwide cohort from the epi-IIRN
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Atia, O.(1);Goren, I.(2)*;Sharar Fischler, T.(2);Loewenberg Weisband, Y.(3);Greenfeld, S.(4);Kariv, R.(5);Ledderman, N.(6);Matz, E.(7);Magen Rimon, R.(8);Dotan, I.(2);Turner, D.(1);Yanai, H.(2);
Created: Friday, 14 July 2023, 11:05 AM
P467: A comparison of thiopurines vs. anti-TNF-α therapy in steroid-dependent ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Hosomi*, M. Ohira, H. Yamagami, R. Nakata, N. Sugita, Y. Nishida, S. Itani, T. Yukawa, N. Kamata, K. Otani, Y. Nagami, F. Tanaka, K. Taira, T. Tanigawa, T. Watanabe, Y. Fujiwara

Created: Thursday, 21 February 2019, 9:14 AM
P467: Circulating CD8 α4β7+ and CD8b7+ memory T cells as early biomarkers of clinical response to vedolizumab in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Gonzalez-Vivo1, M. K. Lund Tiirikainen2, C. de Jesús Gi2, E. Ruiz-Romeu2, L. Sans2, L. Canillas1, M. Andreu1, L. F. Santamaria-Babí2, L. Marquez*1

Created: Friday, 22 February 2019, 9:41 AM
P467: Maintenance of quality of life improvement in a phase 3 study of tofacitinib for patients with moderately to severely active ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Panés J.*1, Rubin D.T.2, Vermeire S.3, Lindsay J.O.4, Sands B.E.5, Su C.6, Friedman G.6, Zhang H.6, Kayhan C.6, Manuchehri A.7, Healey P.8

Created: Wednesday, 20 February 2019, 10:36 AM
P467: Perception Gap between Patients with Inflammatory Bowel Disease (IBD) and Physicians in China: A Cross-sectional Study
Year: 2021
Source: ECCO'21 Virtual
Authors: Liang , J.(1);Cao , Q.(2);Chen , M.(3);Wu , K.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P467: The validation of the Crohn’s and Ulcerative Colitis Questionnaire–12 Plus (CUCQ-12 plus): a short quality-of-life measure for inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Shwana*1, L. Alrubaiy1, H. Hutchings2, J. Williams2, A. Protheroe3, K. Mortier4

Created: Friday, 22 February 2019, 9:49 AM
P467: Therapeutic drug monitoring of biologics in Inflammatory Bowel Disease: Nordic survey on implementation and barriers in clinical practice
Year: 2022
Source: ECCO'22
Authors: Bjørlykke, K.(1);Jahnsen, J.(1);Brynskov, J.(2);Molander, P.(3);Eberhardson, M.(4);Davidsdottir, L.G.(5);Sipponen, T.(3);Hjortswang, H.(4);Langholz, E.(2);Jørgensen, K.K.(1);Steenholdt, C.(2);
Created: Friday, 11 February 2022, 3:52 PM
P468 Switching from adalimumab originator to ABP 501 biosimilar: a multicentre North Italian study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

B. Barberio1, P. Melatti1, F. Zingone1, L. Bertani2, A. Ferronato3, A. GUBBIOTTI1, D. Massimi4, R. D’Incà1, E.V. Savarino5

Created: Thursday, 30 January 2020, 10:12 AM
P468: Analysis of international spontaneous reporting system databases for safety of corticosteroids in Inflammatory Bowel Disease: The Determinants, Incidence and consequences of Corticosteroid Excess (DICE)-impact study
Year: 2021
Source: ECCO'21 Virtual
Authors: Raine, T.(1);Bokemeyer, B.(2);Finney-Hayward, T.(3);Munsaka, M.(4);Liu, M.(4);Louis, E.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P468: Association of uncontrolled disease with quality of life and healthcare resource utilisation in Ulcerative Colitis patients treated with advanced therapy in the United States
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Igho-Osagie, E.(1);Knight, H.(2);Barlow, S.(3);Harvey, N.(2);Khandker, R.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P468: Etrolizumab treatment improves histological activity as assessed by the Robarts histopathology index
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Feagan B.G.1, De Hertogh G.2, Peyrin-Biroulet L.3, Rubin D.T.4, Maciuca R.5, McBride J.5, Arulmani U.*5, Scherl A.5

Created: Wednesday, 20 February 2019, 10:36 AM
P468: Evaluation of work productivity and activity impairment in moderate-to-severe ulcerative colitis participants treated with ozanimod in the phase 3 True North study
Year: 2022
Source: ECCO'22
Authors: Floden, L.(1);Pham, T.P.(2);Kumar, J.(3);Becker, B.(3);Shaw, J.W.(3);Tencer, T.(3);
Created: Friday, 11 February 2022, 3:52 PM
P468: Long-term efficacy and safety of thiopurine in biologic-naïve Japanese patients with ulcerative colitis: a multicentre retrospective study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. Takagi*1, M. Matsuura2, S. Yamada2, S. Bamba3, Y. Hotta1, K. Uchiyama1, Y. Naito1, H. Nakase2, A. Andoh3, T. Kawamura4, S. Katsushima5, T. Kusaka6, H. Obata7, T. Kogawa8

Created: Friday, 22 February 2019, 9:49 AM
P468: Long-term function after transanal vs. transabdominal ileal pouch-anal anastomosis for ulcerative colitis: a multi-centre cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Chandrasinghe1, M. Carvello2, K. Wasmann3, P. Tanis3, J. Warusavitarne5, A. Spinelli*2, W. Bemelman3

Created: Friday, 22 February 2019, 9:41 AM
P468: Microscopic colitis: systematic analysis of 200 adult patients with a mean follow-up of 4 years
Year: 2018
Source: ECCO '18 Vienna
Authors:

H. Maye1*, E. Safroneeva2, S. Godat1, A. Schoepfer1

Created: Thursday, 21 February 2019, 9:14 AM